Yokoyama, Keitaro
Fukagawa, Masafumi
Akiba, Takashi
Nakayama, Masaaki
Ito, Kyoko
Hanaki, Koji
Wolf, Myles http://orcid.org/0000-0002-1127-1442
Hirakata, Hideki
Article History
Received: 30 January 2019
Accepted: 4 June 2019
First Online: 20 June 2019
Competing Interests
: K.Y., M.F., T.A. and H.H. received consulting fees from Torii Pharmaceutical Co. Ltd. and Japan Tobacco, Inc. M.N. received research funding and consulting fees from Torii Pharmaceutical Co. Ltd. and Japan Tobacco, Inc. M.W. received consulting fees from Torii Pharmaceutical Co. Ltd. and Keryx Biopharmaceuticals, Inc. K.I. is an employee of Torii Pharmaceutical Co. Ltd. and K.H. is an employee of Japan Tobacco Inc. The study was conducted by the funding from Torii Pharmaceutical Co., Ltd. (Tokyo, Japan) and Japan Tobacco Inc. (Tokyo, Japan).